Flu and RSV Increase Demand for Antibiotics and Antivirals
An intense early flu season, coupled with a pediatric rise in respiratory illnesses, has left families frantically searching for medicines that are in short supply. (Source: NYT Health)
Source: NYT Health - November 24, 2022 Category: Consumer Health News Authors: Andrew Jacobs and Roni Caryn Rabin Tags: Drugs (Pharmaceuticals) Antibiotics Shortages Influenza Respiratory Syncytial Virus (RSV) Coronavirus (2019-nCoV) Tamiflu (Drug) Hospitals Children and Childhood Food and Drug Administration Disease Rates United States amoxicillin Source Type: news
Flu and R.S.V. Increase Demand for Antibiotics and Antivirals
An intense early flu season, coupled with a pediatric rise in respiratory illnesses, has left families frantically searching for medicines that are in short supply. (Source: NYT Health)
Source: NYT Health - November 24, 2022 Category: Consumer Health News Authors: Andrew Jacobs and Roni Caryn Rabin Tags: Drugs (Pharmaceuticals) Antibiotics Shortages Influenza Respiratory Syncytial Virus (RSV) Coronavirus (2019-nCoV) Tamiflu (Drug) Hospitals Children and Childhood Food and Drug Administration Disease Rates United States amoxicillin Source Type: news
America runs out of FOUR child antibiotics and flu drugs as kids bear brunt of 'tripledemic'
Four crucial drugs for fighting respiratory illnesses are in short supply in America amid the 'tripledemic'. It has been hard to find Augmentin, amoxicillin, Tamiflu and albuterol. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2022 Category: Consumer Health News Source Type: news
What Happens If I Get COVID-19 and the Flu at the Same Time?
So far, COVID-19 has come with one small silver lining for health: cases of influenza have dropped dramatically. During the first flu season during the pandemic, lockdowns kept people indoors and away from one another, limiting the virus’ ability to spread. And once people began mingling more during the next flu seasons, widespread use of masks blocked influenza’s chances of infecting large numbers of people.
But that could change this flu season, as mask mandates have disappeared and more people are interacting in close quarters in school, workplaces, sports events, public transport, and more. Health experts a...
Source: TIME: Health - October 11, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Early Tamiflu Linked to Better Outcomes for Kids Hospitalized for the Flu
(MedPage Today) -- Early use of oseltamivir (Tamiflu) in children hospitalized with influenza was associated with better outcomes, according to a multicenter propensity score-weighted analysis.
Among over 55,000 children, treatment with oseltamivir... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - September 19, 2022 Category: Infectious Diseases Source Type: news
Drug combo can produce stronger flu treatment, study finds
Combining antiviral drugs such as Tamiflu, which has been used for decades, with antibody therapies may provide a one-two punch to knock out influenza, research published Tuesday suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 16, 2022 Category: Consumer Health News Source Type: news
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Investor Update - August 12, 2022 Category: Pharmaceuticals Source Type: news
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Media News - August 12, 2022 Category: Pharmaceuticals Source Type: news
As Omicron Hits, COVID-19 Case Counts Don ’t Mean What They Used To
America has begun the gradual process of accepting that COVID-19 is going to be endemic—meaning it will always be present in the population to some degree—due to inherent properties of the virus (animal reservoirs, high transmissibility, long period of infectiousness, symptoms similar to other pathogens), and will remain so for the foreseeable future. However, the U.S. has an impressive suite of tools to deal with this reality. Vaccine eligibility is widening and boosters are available for all adults who want one. Two effective oral antiviral drugs that prevent hospitalizations and death in people newly infecte...
Source: TIME: Health - December 16, 2021 Category: Consumer Health News Authors: Monica Gandhi and Leslie Bienen Tags: Uncategorized COVID-19 Source Type: news
Small Cluster of Oseltamivir-Resistant Influenza Identified Small Cluster of Oseltamivir-Resistant Influenza Identified
Four cases of oseltamivir-resistant influenza A(H1N1)pdm09 infection were identified among individuals living in a border detention center in Texas, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 24, 2021 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
MSN Labs launches black fungus drug Posaconazole in India
MSN Labs had earlier launched a Covid treatment portfolio of Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg, Oselow (Oseltamivir) in 75 mg capsules and also obtained a voluntary license for Baridoz (Baricitinib) last week from Eli Lilly. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 21, 2021 Category: Pharmaceuticals Source Type: news
MSN Labs ties up with Eli Lilly for baricitinib in India
As part of the COVID treatment range, MSN has already launched Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg and Oselow (Oseltamivir) as 75 mg capsules. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 13, 2021 Category: Pharmaceuticals Source Type: news
End Vaccine Apartheid Before Millions More Die
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, Mar 23 2021 (IPS) At least 85 poor countries will not have significant access to coronavirus vaccines before 2023. Unfortunately, a year’s delay will cause an estimated 2.5 million avoidable deaths in low and lower-middle income countries. As the World Health Organization (WHO) Director-General has put it, the world is at the brink of a catastrophic moral failure.
Anis Chowdhury
Vaccine apartheid
The EU, US, UK, Switzerland, Canada and their allies continue to block the developing country proposal to temporarily suspend the World Trade Organization (WTO) ...
Source: IPS Inter Press Service - Health - March 23, 2021 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Development & Aid Economy & Trade Featured Global Headlines Health Human Rights Humanitarian Emergencies TerraViva United Nations Source Type: news
Oral Antiviral Stops SARS-CoV-2 in its Tracks Oral Antiviral Stops SARS-CoV-2 in its Tracks
Could a Tamiflu-like oral pill to control SARS-CoV-2 stop COVID-19 before it gets severe?Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 9, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
Avian influenza: PGD templates, PHE
Patient group direction (PGD) templates for the supply of oseltamivir for pre and post exposure prophylaxis of avian influenza (flu). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 25, 2021 Category: Consumer Health News Source Type: news
